The Critical Need for Inclusive Biobanking in Endometrial Cancer
Endometrial
**Formulating Initial Draft**
I’m now formulating the first draft, mapping the content to the headings provided. I’m expanding on the Return of Value (ROV) priorities in my mind, outlining how genetics and lifestyle results will be presented. The SISTER Study’s methodology is also being fleshed out, and I’m ensuring there is a strong emphasis on the importance of trust, and the 14 recommendations, for the clinicians.
cancer (EC) presents one of the most stark examples of racial health disparities in oncology. While the incidence of EC is rising across all demographics, Black women experience significantly higher mortality rates and are more likely to be diagnosed with aggressive, non-endometrioid histological subtypes compared to their white counterparts. Understanding the molecular drivers of these disparities is essential for developing precision medicine interventions. However, the scientific community faces a persistent hurdle: the underrepresentation of Black women in biobanking and translational research.
Biobanks serve as the foundation for modern genomic and proteomic research. Without adequate representation of diverse populations, the findings derived from these repositories risk being inapplicable to those who suffer the highest disease burden. Traditionally, the lack of participation among Black individuals has been attributed to a lack of trust in medical institutions—a legacy of historical exploitation. Yet, emerging evidence suggests that the focus should shift from ‘fixing’ the patient to optimizing the research infrastructure. The recent study published in Gynecologic Oncology by Salehipour and colleagues investigates how ‘Return of Value’ (ROV) practices can bridge this gap by aligning research goals with the priorities of Black EC survivors.
Study Design and Methodology: A Community-Engaged Approach
The research leveraged the infrastructure of The Social Interventions for Support during Treatment for Endometrial Cancer and Recurrence (SISTER) Study. The SISTER Study is a community-engaged platform specifically designed to support Black women through the continuum of cancer care. By utilizing this existing network, the researchers conducted a mixed-methods study to identify what Black EC survivors value most when participating in biobanking.
Study Population and Recruitment
The researchers recruited 56 Black EC survivors, including 38 individuals who had already completed the SISTER study. This cohort provided a unique perspective from individuals who were already familiar with the research environment, alongside those who were new to the process. The recruitment strategy emphasized community engagement, ensuring that the participants felt their voices were central to the scientific inquiry.
Mixed-Methods Framework
The study employed two primary data collection phases:
1. Quantitative Survey (n=50): Participants were asked to prioritize various ROV items, ranging from monetary compensation to the return of clinical and genetic results.
2. Qualitative Focus Groups (n=13): These sessions were designed to elicit the rationale behind the survey results and explore perceived benefits and risks. The focus groups also aimed to identify novel ROV items that were not captured in the initial survey.
Data analysis involved descriptive and inferential statistics for the survey, while the focus group transcripts underwent directed thematic content analysis. Crucially, a community advisory council co-developed 14 specific recommendations for research conduct based on these findings.
Key Findings: Rethinking Incentives and Value
The results of the study challenge several conventional assumptions about research incentives. While monetary compensation is often the default method for encouraging participation, this study found that Black EC survivors prioritized other forms of value much more highly.
The Primacy of Knowledge and Results
In the survey, the highest-rated ROV items were the return of results regarding genetics and lifestyle factors that influence disease risk. Participants expressed a profound desire to understand the ‘why’ behind their diagnosis. This interest was not merely academic; it was deeply rooted in a commitment to family and community health. Many survivors viewed their participation as a way to provide their daughters, sisters, and nieces with information that could mitigate their own future risks.
Trust, Transparency, and Social Connection
The focus group themes confirmed that a willingness to participate in biobanking is inextricably linked to trust. However, trust was not viewed as a static trait but as a dynamic quality built through transparency. Participants wanted to know where their samples were going, who was profiting from them, and how the research would eventually benefit the Black community. Novel ROV items emerged during these discussions, including the desire for ongoing EC knowledge and a sense of social connection with other survivors and researchers.
Low Priority for Monetary Compensation
Interestingly, monetary compensation was rated significantly lower than the return of medical information. This suggests that for many Black women, the transaction of biobanking is not financial but relational. They are looking for a partnership where their contribution of biological material is met with a meaningful return of actionable health information.
A Framework for Equitable Research: 14 Community-Validated Recommendations
One of the most significant outputs of this study is the set of 14 recommendations co-developed with the community advisory council. These recommendations provide a practical roadmap for investigators looking to enhance engagement in translational research. Key themes include:
1. Transparency in Data Usage
Researchers must clearly articulate the ‘life cycle’ of a biospecimen. This includes who has access to the data, whether it will be sold to pharmaceutical companies, and how individual privacy is protected. Transparency serves as the antidote to historical skepticism.
2. Meaningful Return of Results
Studies should be designed with the infrastructure to return individual or aggregate results to participants. Even if the results do not have immediate clinical utility, the act of sharing findings acknowledges the participant as a stakeholder in the scientific process.
3. Community Integration
Research should not be a ‘one-off’ interaction. Engaging with community organizations and maintaining long-term relationships with participants fosters a sense of belonging and mutual respect. This includes providing educational resources about endometrial cancer that extend beyond the specific requirements of the study.
4. Cultural Humility and Competence
The study emphasizes that engagement strategies must be culturally resonant. This involves recognizing the unique social and historical context of Black women in the healthcare system and ensuring that communication is respectful, accessible, and empathetic.
Expert Commentary: Shifting the Paradigm
This research represents a critical shift in how we approach health disparities in oncology. For too long, the ‘underrepresentation’ of Black women has been framed as a problem of recruitment. Salehipour et al. demonstrate that it is actually a problem of engagement and value alignment. By focusing on Return of Value, we move away from an extractive model of research—where samples are taken and nothing is given back—toward a reciprocal model.
From a clinical perspective, these findings are vital. Clinicians are often the first point of contact for biobank recruitment. Understanding that their patients may value genetic insights for their families more than a gift card can change how these conversations are framed. Furthermore, the emphasis on lifestyle factors highlights an unmet need for survivorship care that integrates molecular research with practical wellness strategies.
However, implementing these recommendations is not without challenges. Returning genetic results requires robust genetic counseling infrastructure, and maintaining long-term community engagement requires sustained funding that often exceeds the standard three-to-five-year grant cycle. Policy changes at the level of the NIH and other funding bodies may be necessary to incentivize and support these ROV practices.
Conclusion: Moving Toward Justice in Translational Science
The study by Salehipour and colleagues provides a compelling evidence base for reimagining biobanking engagement. By prioritizing the return of results, transparency, and social connection, researchers can build the trust necessary to ensure that Black women are no longer left out of the molecular revolution in endometrial cancer care.
The 14 recommendations developed through this community-engaged process are not just applicable to endometrial cancer; they offer a template for any research area struggling with the underrepresentation of marginalized groups. As we move toward a future of precision medicine, the inclusion of those most affected by disease is not just a scientific necessity—it is a matter of social justice.
References
1. Salehipour D, Tadess B, Moore A, et al. Enhancing engagement in biobanking research among Black women with endometrial cancer. Gynecologic oncology. 2026;208:32-40. PMID: 41833227.
2. Doll KM, et al. The SISTER Study: Community-engaged approaches to endometrial cancer disparities. Journal of Clinical Oncology. 2023.
3. National Cancer Institute. Cancer Stat Facts: Uterine Cancer. https://seer.cancer.gov/statfacts/html/corp.html.